3-167790274-T-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001122752.2(SERPINI1):c.251-98T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.397 in 863,804 control chromosomes in the GnomAD database, including 71,012 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.45   (  16122   hom.,  cov: 32) 
 Exomes 𝑓:  0.39   (  54890   hom.  ) 
Consequence
 SERPINI1
NM_001122752.2 intron
NM_001122752.2 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.492  
Publications
12 publications found 
Genes affected
 SERPINI1  (HGNC:8943):  (serpin family I member 1) This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008] 
SERPINI1 Gene-Disease associations (from GenCC):
- progressive myoclonus epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- familial encephalopathy with neuroserpin inclusion bodiesInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). 
BP6
Variant 3-167790274-T-C is Benign according to our data. Variant chr3-167790274-T-C is described in ClinVar as Benign. ClinVar VariationId is 1230249.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.6  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| SERPINI1 | NM_001122752.2 | c.251-98T>C | intron_variant | Intron 2 of 8 | ENST00000446050.7 | NP_001116224.1 | ||
| SERPINI1 | NM_005025.5 | c.251-98T>C | intron_variant | Intron 2 of 8 | NP_005016.1 | |||
| SERPINI1 | XM_017006618.3 | c.251-98T>C | intron_variant | Intron 2 of 8 | XP_016862107.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SERPINI1 | ENST00000446050.7 | c.251-98T>C | intron_variant | Intron 2 of 8 | 1 | NM_001122752.2 | ENSP00000397373.2 | |||
| SERPINI1 | ENST00000295777.9 | c.251-98T>C | intron_variant | Intron 2 of 8 | 1 | ENSP00000295777.5 | ||||
| SERPINI1 | ENST00000472747.2 | c.251-98T>C | intron_variant | Intron 2 of 4 | 3 | ENSP00000420561.2 | ||||
| SERPINI1 | ENST00000472941.5 | c.251-98T>C | intron_variant | Intron 2 of 2 | 3 | ENSP00000420133.1 | 
Frequencies
GnomAD3 genomes  0.447  AC: 67980AN: 151924Hom.:  16100  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
67980
AN: 
151924
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.386  AC: 274509AN: 711762Hom.:  54890   AF XY:  0.378  AC XY: 142270AN XY: 376098 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
274509
AN: 
711762
Hom.: 
 AF XY: 
AC XY: 
142270
AN XY: 
376098
show subpopulations 
African (AFR) 
 AF: 
AC: 
11075
AN: 
18402
American (AMR) 
 AF: 
AC: 
12044
AN: 
36516
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
4959
AN: 
20532
East Asian (EAS) 
 AF: 
AC: 
10413
AN: 
34266
South Asian (SAS) 
 AF: 
AC: 
17210
AN: 
65840
European-Finnish (FIN) 
 AF: 
AC: 
22563
AN: 
50258
Middle Eastern (MID) 
 AF: 
AC: 
782
AN: 
2750
European-Non Finnish (NFE) 
 AF: 
AC: 
181865
AN: 
448008
Other (OTH) 
 AF: 
AC: 
13598
AN: 
35190
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.506 
Heterozygous variant carriers
 0 
 8421 
 16841 
 25262 
 33682 
 42103 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 2916 
 5832 
 8748 
 11664 
 14580 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.448  AC: 68048AN: 152042Hom.:  16122  Cov.: 32 AF XY:  0.442  AC XY: 32864AN XY: 74328 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
68048
AN: 
152042
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
32864
AN XY: 
74328
show subpopulations 
African (AFR) 
 AF: 
AC: 
25153
AN: 
41472
American (AMR) 
 AF: 
AC: 
5503
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
829
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
1621
AN: 
5158
South Asian (SAS) 
 AF: 
AC: 
1234
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
4823
AN: 
10554
Middle Eastern (MID) 
 AF: 
AC: 
85
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
27586
AN: 
67964
Other (OTH) 
 AF: 
AC: 
840
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1852 
 3705 
 5557 
 7410 
 9262 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 606 
 1212 
 1818 
 2424 
 3030 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1089
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.